向精神薬の世界市場2023-2030

向精神薬の世界市場は予測期間（2023-2030年）にCAGR 14.1％で成長すると予測されています。ブレインブースターやスマートドラッグに対する需要の高まりが、世界の向精神薬市場の成長を促す主な要因となっています。多くの学生や専門家が集中力や記憶力を高めるためにこれらのスマートドラッグを消費しています。合成原料と天然原料の両方を使用した継続的な製品開発は、製品需要を促進すると予想されています。例えば、2020年10月、オーストラリアを拠点とする向精神薬の新興企業Neuratech社は、BoostとCalmと名付けられた集中力とストレスのための2種類の脳の健康サプリメントを発売しました。Boostは集中力とエネルギーの向精神薬であり、Calmはストレスと睡眠の向精神薬です。さらに、消費者が天然の向精神薬を求めているため、コーヒーや、ブラフミー、アークティックルート、ウコン、朝鮮人参、松樹皮などの天然成分を含むサプリメントなどのオーガニック向精神薬の需要が急増しました。

スポーツジムの会員数がここ10年で急激に増加したため、スポーツジム文化はますます人気が高まっています。そのため、ミレニアル世代はフィットネス活動に熱心であることが知られており、向精神薬のようなパフォーマンス栄養食品の人気が高まっています。向精神薬に関する研究開発活動の増加は、市場成長に有利な機会を提供すると期待されています。しかし、医薬品の開発と流通に関連する高コストが市場の成長を抑制する可能性があります。また、向精神薬の投与に伴う副作用も、予測期間中の市場成長を抑制する可能性があります。

セグメント別展望

ドリンク剤サブセグメントが世界の向精神薬市場で顕著な成長を維持すると予測される

形状セグメントの中でも、ドリンクのサブセグメントが世界市場で突出した成長を保持すると予測されています。このセグメントの成長を支える主な要因には、カプセルや錠剤の形の向精神薬やスマートドラッグの開発やイントロダクションの増加があります。例えば、2020年1月には、飲料ブランドの新興企業であるSun Chaserが公式ウェブサイトで飲料の予約販売を開始しました。この飲料は、カフェインと酒を含まない炭酸アルコール代替品です。サンチェイサーは、L-テアニンと冬虫夏草をアルコールの代替品として活用しています。この発売を通じて、同ブランドは、機能性向知性成分の幅広い市場への参入を目指しています。

地域別展望

北米のサプリメント市場全体は飛躍的に成長しており、脳の生産性を高めるためにサプリメントを使用することが、向精神薬への道を開くのに役立っています。そのため、オンラインショップと実店舗の両方で、ティーンエイジャーから高齢者まで幅広い消費者のニーズに応えるため、ヌートロピック・サプリメントの目立つ棚を設けています。

アジア太平洋地域は世界の向精神薬市場において著しいCAGRで成長すると予想される

すべての地域の中で、アジア太平洋地域は予測期間中にかなりのCAGRで成長すると予測されています。インドや中国などの経済成長国における個人の健康に対する意識の高まりは、世界の向精神薬市場の成長を促進する重要な要因の一つです。心臓病、がん、糖尿病、脳卒中、関節炎などの慢性疾患は最近増加傾向にあります。国際糖尿病連合（IDF）によると、2019年にはこの地域で20～79歳の約2億5,000万人の成人が糖尿病と共存しています。これらの数字は、食習慣の変化や不健康な食事への傾倒の増加により、一定期間中にさらに増加すると予想されています。慢性疾患の有病率の増加は、向精神薬の必要性を促し、市場の地域的成長を促進します。

目次

第1章 レポート概要

• 業界の現状分析と成長ポテンシャルの展望
• 調査方法とツール
• 市場内訳
  • セグメント別
  • 地域別

第2章 市場概要と洞察

• 調査範囲
• アナリストの洞察と現在の市場動向
  • 主な調査結果
  • 推奨事項
  • 結論

第3章 競合情勢

• 主要企業分析
• Pfizer Inc.
  • 概要
  • 財務分析
  • SWOT分析
  • 最近の動向
• GlaxoSmithKline plc
  • 会社概要
  • 財務分析
  • SWOT分析
  • 最近の動向
• Novartis AG
  • 概要
  • 財務分析
  • SWOT分析
  • 最近の動向
• 主要戦略分析

第4章 市場セグメンテーション

• 向精神薬の世界市場：形態別
  • カプセル/錠剤
  • 粉末
  • ドリンク剤
• 向精神薬の世界市場：流通チャネル別
  • オフライン
  • オンライン

第5章 地域分析

• 北米
  • 米国
  • カナダ
• 欧州
  • 英国
  • ドイツ
  • イタリア
  • スペイン
  • フランス
  • その他欧州
• アジア太平洋
  • 中国
  • インド
  • 日本
  • 韓国
  • その他アジア太平洋地域
• 世界のその他の地域

第6章 企業プロファイル

• AstraZeneca Plc
• Cephalon A/S
• GlaxoSmithKline plc
• Johnson & Johnson Private Ltd.
• Kimera Koffee
• Koios Beverage Corp
• Mental Mojo, LLC
• Mylan N.V.
• Novartis AG
• Onnit Labs, Inc.
• Opti-Nutra Ltd.
• Pfizer Inc.
• Reckitt Benckiser Group PLC
• Reckitt Benckiser Group plc
• Sanofi SA
• Savvy Beverage
• Teva Pharmaceutical Industries Ltd.
• TruBrain Inc.
• Wolfson Brands（Noocube）
• Zhou Nutrition LLC

LIST OF TABLES

• 1. GLOBAL NOOTROPICS MARKET RESEARCH AND ANALYSIS BY FORM, 2022-2030 ($ MILLION)
• 2. GLOBAL NOOTROPICS CAPSULES/ TABLETS MARKET RESEARCH AND ANALYSIS BY REGION,2022-2030 ($ MILLION)
• 3. GLOBAL NOOTROPICS POWDER MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
• 4. GLOBAL NOOTROPICS DRINKS MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
• 5. GLOBAL NOOTROPICS MARKET RESEARCH AND ANALYSIS BY DISTRIBUTION CHANNEL, 2022-2030 ($ MILLION)
• 6. GLOBAL NOOTROPICS IN OFFLINE MARKET RESEARCH AND ANALYSIS, 2022-2030 ($ MILLION)
• 7. GLOBAL NOOTROPICS IN ONLINE MARKET RESEARCH AND ANALYSIS, 2022-2030 ($ MILLION)
• 8. GLOBAL NOOTROPICS MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
• 9. NORTH AMERICAN NOOTROPICS MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2022-2030 ($ MILLION)
• 10. NORTH AMERICAN NOOTROPICS MARKET RESEARCH AND ANALYSIS BY FORM, 2022-2030 ($ MILLION)
• 11. NORTH AMERICAN NOOTROPICS MARKET RESEARCH AND ANALYSIS BY DISTRIBUTION CHANNEL, 2022-2030 ($ MILLION)
• 12. EUROPEAN NOOTROPICS MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2022-2030 ($ MILLION)
• 13. EUROPEAN NOOTROPICS MARKET RESEARCH AND ANALYSIS BY FORM, 2022-2030 ($ MILLION)
• 14. EUROPEAN NOOTROPICS MARKET RESEARCH AND ANALYSIS BY DISTRIBUTION CHANNEL, 2022-2030 ($ MILLION)
• 15. ASIA- PACIFIC NOOTROPICS MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2022-2030 ($ MILLION)
• 16. ASIA- PACIFIC NOOTROPICS MARKET RESEARCH AND ANALYSIS BY FORM, 2022-2030 ($ MILLION)
• 17. ASIA- PACIFIC NOOTROPICS MARKET RESEARCH AND ANALYSIS BY DISTRIBUTION CHANNEL, 2022-2030 ($ MILLION)
• 18. REST OF THE WORLD NOOTROPICS MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2022-2030 ($ MILLION)
• 19. REST OF THE WORLD NOOTROPICS MARKET RESEARCH AND ANALYSIS BY FORM, 2022-2030 ($ MILLION)
• 20. REST OF THE WORLD NOOTROPICS MARKET RESEARCH AND ANALYSIS BY DISTRIBUTION CHANNEL, 2022-2030 ($ MILLION)

LIST OF FIGURES

• 1. GLOBAL NOOTROPICS MARKET SHARE BY FORM, 2022 VS 2030 (%)
• 2. GLOBAL NOOTROPICS CAPSULES/TABLETS MARKET SHARE BY REGION, 2022 VS 2030 (%)
• 3. GLOBAL NOOTROPICS POWDER MARKET SHARE BY REGION, 2022 VS 2030 (%)
• 4. GLOBAL NOOTROPICS DRINKS MARKET SHARE BY REGION, 2022 VS 2030 (%)
• 5. GLOBAL NOOTROPICS MARKET SHARE ANALYSIS BY DISTRIBUTION CHANNEL, 2022-2030 ($ MILLION)
• 6. GLOBAL NOOTROPICS IN OFFLINE MARKET SHARE BY REGION, 2022 VS 2030 (%)
• 7. GLOBAL NOOTROPICS IN ONLINE MARKET SHARE BY REGION, 2022 VS 2030 (%)
• 8. GLOBAL NOOTROPICS MARKET SHARE BY REGION, 2022 VS 2030 (%)
• 9. US NOOTROPICS MARKET SIZE, 2022-2030 ($ MILLION)
• 10. CANADA NOOTROPICS MARKET SIZE, 2022-2030 ($ MILLION)
• 11. UK NOOTROPICS MARKET SIZE, 2022-2030 ($ MILLION)
• 12. FRANCE NOOTROPICS MARKET SIZE, 2022-2030 ($ MILLION)
• 13. GERMANY NOOTROPICS MARKET SIZE, 2022-2030 ($ MILLION)
• 14. ITALY NOOTROPICS MARKET SIZE, 2022-2030 ($ MILLION)
• 15. SPAIN NOOTROPICS MARKET SIZE, 2022-2030 ($ MILLION)
• 16. REST OF EUROPE NOOTROPICS MARKET SIZE, 2022-2030 ($ MILLION)
• 17. INDIA NOOTROPICS MARKET SIZE, 2022-2030 ($ MILLION)
• 18. CHINA NOOTROPICS MARKET SIZE, 2022-2030 ($ MILLION)
• 19. JAPAN NOOTROPICS MARKET SIZE, 2022-2030 ($ MILLION)
• 20. SOUTH KOREA NOOTROPICS MARKET SIZE, 2022-2030 ($ MILLION)
• 21. REST OF ASIA-PACIFIC NOOTROPICS MARKET SIZE, 2022-2030 ($ MILLION)
• 22. REST OF THE WORLD NOOTROPICS MARKET SIZE, 2022-2030 ($ MILLION)

Title: Global Nootropics Market Size, Share & Trends Analysis Report by Form (Capsules/ Tablets, Powder, and Drinks), and by Distribution Channel (Online and Offline) Forecast Period (2023-2030).

The global nootropics market is anticipated to grow at a CAGR of 14.1% during the forecast period (2023-2030). The increasing demand for brain boosters and smart drugs is a key factor driving the growth of the global nootropics market. A large number of students and professionals consume these smart drugs to improve focus and memory. Continuous product development using both synthetic and natural raw materials is anticipated to fuel the product demand. For instance, in October 2020, Australia-based nootropic start-up Neuratech launched 2 brain health supplements for focus and stress, named Boost and Calm. Boost is a focus and energy nootropic, while Calm is a stress and sleep nootropic. Furthermore, the demand for organic nootropics such as coffee and supplements with natural ingredients such as Brahmi, arctic root, turmeric, ginseng, and pine bark witnessed a surge as consumers are seeking natural nootropics products.

Gym cultures is increasingly becoming popular as gym membership have increased with a higher late in last 10 years. Therefore, performance nutrition foods such as nootropics are gaining popularity among millennial are known to be more involved in fitness activates. Increase in the number of research and development activities regarding nootropics is expected to offer lucrative opportunities to the market growth. However, high cost associated with drug development and distribution may restrain the market growth. The side effects linked with administration of nootropics may also restrain the market growth during the forecast period.

Segmental Outlook

The global nootropics market is segmented on the form and distribution channel. Based on the form, the market is sub-segmented into capsules/tablets, powder, and drinks. On the basis of distribution channel, the market is sub-segmented into online and offline. Among the distribution channels, the offline sub-segment is expected to hold a prominent share of the global market, owing to the growing penetration of independent retail companies such as Walmart Tesco, and others. The retail giants further bolster the product visibility and attract a larger consumer base.

Drinks Sub-Segment is Anticipated to hold a Prominent Growth in the Global Nootropics Market

Among the form segment, the drinks sub-segment is expected to hold a prominent growth in the market across the globe. The primary factor supporting the segmental growth includes the rising development and introduction of nootropics or smart drugs in the form of either capsule or tablet. For instance, in January 2020, Sun Chaser, a beverage brand start-up launched pre-orders of their beverages on its official website. The beverage is a carbonated alcohol alternative which does not contain caffeine and booze. Sun Chaser leverages L-theanine and cordyceps for an alcohol alternative. Through this launch, the brand aims to tap into the broad market of functional nootropic ingredients.

Regional Outlook

The global nootropics market is further segmented based on geography including North America (the US, and Canada), Europe (UK, Italy, Spain, Germany, France, and the Rest of Europe), Asia-Pacific (India, China, Japan, South Korea, and Rest of Asia), and the Rest of the World (the Middle East & Africa, and Latin America. Among these, North America is anticipated to hold a prominent share of the market across the globe, owing to the presence of key market players. The rising focus on health along with the rising awareness regarding nootropics is further driving the product demand in this region.

The overall supplements market in North America is growing exponentially, and the use of supplements to enhance the productivity of the brain has helped pave the way for nootropics. Retailers, both online and brick-and-mortar stores, are thereby creating prominent shelf lines for nootropics supplements to cater to the needs of consumers, ranging from teenagers to older adults.

Global Nootropics Market Growth, by Region 2023-2030

Source: OMR Analysis

The Asia-Pacific Region is Expected to Grow at a Significant CAGR in the Global Nootropics Market

Among all regions, the Asia-Pacific region is anticipated to grow at a considerable CAGR over the forecast period. Increasing awareness towards personal health in growing economies such as India & China is one of the key factors driving the growth of the global nootropics market. Chronic diseases such as heart disease, cancer, diabetes, stroke, and arthritis have been on the rise, in recent times. As per the International Diabetes Federation (IDF), around 250 million adults in the age range of 20-79 years were living with diabetes in the region in 2019. These numbers are further expected to rise over a certain period owing to the changing eating habits and more inclination towards unhealthy food diets. The rise in the prevalence of chronic diseases prompts the need for nootropics, which drives the regional growth of the market.

Market Players Outlook

The major companies serving the nootropics market include Pfizer Inc., GlaxoSmithKline plc, Novartis AG, Mylan N.V., and Teva Pharmaceutical Industries Ltd. Among others. The market players are considerably contributing to the market growth by the adoption of various strategies including funding for R&D, and new product development, mergers & acquisition, and distribution network expansion among others to remain competitive in the market place. For instance, in October 2022, Shine Drink, Australia's first energy nootropic drink developed with natural nootropics has launched into Woolworths stores nationwide. Additionally, in July 2021, Snack bars was hoping to raise $ 2,48,132 to progress its mission to get true functional nutrition into the hands of the mass market.

The Report Covers:

• Market value data analysis of 2022 and forecast to 2030.
• Annualized market revenues ($ million) for each market segment.
• Country-wise analysis of major geographical regions.
• Key companies operating in the global nootropics market. Based on the availability of data, information related to new product launches, and relevant news is also available in the report.
• Analysis of business strategies by identifying the key market segments positioned for strong growth in the future.
• Analysis of market-entry and market expansion strategies.
• Competitive strategies by identifying 'who-stands-where' in the market.

Table of Contents

1. Report Summary

• Current Industry Analysis and Growth Potential Outlook
• 1.1. Research Methods and Tools
• 1.2. Market Breakdown
  • 1.2.1. By Segments
  • 1.2.2. By Region

2. Market Overview and Insights

• 2.1. Scope of the Report
• 2.2. Analyst Insight & Current Market Trends
  • 2.2.1. Key Findings
  • 2.2.2. Recommendations
  • 2.2.3. Conclusion

3. Competitive Landscape

• 3.1. Key Company Analysis
• 3.2. Pfizer Inc..
  • 3.2.1. Overview
  • 3.2.2. Financial Analysis
  • 3.2.3. SWOT Analysis
  • 3.2.4. Recent Developments
• 3.3. GlaxoSmithKline plc
  • 3.3.1. Overview
  • 3.3.2. Financial Analysis
  • 3.3.3. SWOT Analysis
  • 3.3.4. Recent Developments
• 3.4. Novartis AG
  • 3.4.1. Overview
  • 3.4.2. Financial Analysis
  • 3.4.3. SWOT Analysis
  • 3.4.4. Recent Developments
• 3.5. Key Strategy Analysis

4. Market Segmentation

• 4.1. Global Nootropics Market by Form
  • 4.1.1. Capsules/ Tablets
  • 4.1.2. Powder
  • 4.1.3. Drinks
• 4.2. Global Nootropics Market by Distribution Channel
  • 4.2.1. Offline
  • 4.2.2. Online

5. Regional Analysis

• 5.1. North America
  • 5.1.1. United States
  • 5.1.2. Canada
• 5.2. Europe
  • 5.2.1. UK
  • 5.2.2. Germany
  • 5.2.3. Italy
  • 5.2.4. Spain
  • 5.2.5. France
  • 5.2.6. Rest of Europe
• 5.3. Asia-Pacific
  • 5.3.1. China
  • 5.3.2. India
  • 5.3.3. Japan
  • 5.3.4. South Korea
  • 5.3.5. Rest of Asia-Pacific
• 5.4. Rest of the World

6. Company Profiles

• 6.1. AstraZeneca Plc
• 6.2. Cephalon A/S
• 6.3. GlaxoSmithKline plc
• 6.4. Johnson & Johnson Private Ltd.
• 6.5. Kimera Koffee
• 6.6. Koios Beverage Corp
• 6.7. Mental Mojo, LLC
• 6.8. Mylan N.V.
• 6.9. Novartis AG
• 6.10. Onnit Labs, Inc.
• 6.11. Opti-Nutra Ltd.
• 6.12. Pfizer Inc.
• 6.13. Reckitt Benckiser Group PLC
• 6.14. Reckitt Benckiser Group plc
• 6.15. Sanofi SA
• 6.16. Savvy Beverage
• 6.17. Teva Pharmaceutical Industries Ltd.
• 6.18. TruBrain Inc.
• 6.19. Wolfson Brands (Noocube)
• 6.20. Zhou Nutrition LLC